Tina Moore
speaker
1,621 appearances
16 recordings
2 series
first heard Jan 2025
last heard May 2025
Tina Moore’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
The Dr. Tyna Show · GLP1s and Dementia: What the Latest Science Shows | Quick + Dirty · 1 May 2025
podcast
And the reason I got interested in them originally was because of their neuroprotective benefits. That was what got me looking at them. And when I started finding the data in both rodents and humans, I was like, what? This is not what we're being told. And beyond that, yes, they have a very incredible...
I believe if you break down the mechanisms, I just did a podcast about TERS appetite and metabolic health overall. They look to be protective of metabolic health. They definitely induce weight loss. I don't think it's just because they get you to eat less. I think it's because they actually improve your insulin signaling, your insulin reception. There's a lot of different mechanisms going on here.
They impact the immune system directly and indirectly. They lower inflammation in the brain and throughout the body. All of these things will help with overall cardioprotective benefits, weight loss, neurologic benefits. I mean, they're pretty profound.
So the interpretation here was GLP-1 receptor agonists may offer neuroprotection beyond their cardiovascular benefits, potentially through anti-inflammatory antioxidant and anti-apoptotic mechanisms, that's programmed cell death, at the neuronal level. SGLT2s might have a neuroprotective potential, but data so far does not show a statistically significant dementia risk reduction.
Importantly, while observational studies suggested possible benefits, this meta-analysis only showed a statistically significant dementia reduction for GLP-1 receptor agonists, not the other drugs that they looked at. The conclusion was only the GLP-1 receptor agonists demonstrated a statistically significant reduction in risk for all-cause dementia. This is really exciting.
It's not entirely that groundbreaking if you've been looking at the data though. I get a lot of hate for talking about this peptide and I don't understand why because its neurocognitive impacts are profound. I did a whole podcast episode with Max Lugavere on his Genius Life podcast and we talked specifically about the neurocognitive benefits and I shared some pretty great data there.
Oh, gosh, an eight-page lesson inside my GLP-1 Done Right University. It's an educational program. It's my big course. I have a free four-part video series where you can check out if this is new to you and you're like, wait, what? Ozempic may potentially have these other impacts on the body. getting away from brand name drugs, just GLP-1 agonists in general.
I share with you what the data is looking like around those. So it's a four-part video series and you'll get a new video each day. On the third day, you'll be invited at a discount to participate in my big program, which is for clinicians, but as of right now and for a very short time, it's open to the public too. So it's been open to the public since its inception.
I am shutting the whole thing down. I'm revamping it. And when I relaunch it, only clinicians will be able to gain access to the clinical components of the course. Right now the general public has access to everything as well and it's a beefy course. But I've got a multitude of lessons in there from tip to toe
Beyond that, I talk about why you need all the other treatment components to go along with your GLP-1 agonist journey. It's not just about taking a GLP-1 agonist. You have to have your hormones in order. You have to have your gut health in order. You have to be leading an insulin sensitive lifestyle. You have to be strength training. I have modules on each section of those.
I have a module on how to find a doctor to work with, a good doctor to work with. It's a beefy course, but inside one of the particular modules where I go tip to toe about the benefits of GLP-1s and provide you all the most recent data, we've got a bone health lesson, a brain lesson, a cancer in GLP-1s, interesting information in there, cardiovascular... in GLP-1 lesson.
COVID and long COVID and GLP-1. Gastrointestinal, immune and inflammation, fascinating lesson there. Liver, gallbladder, pancreas, a whole pancreatitis in GLP-1. I'll just let you know on that one, no increased risk of pancreatitis has been seen in virtually any study. So long term, it's just not there. So you can put those rumors to rest.
Musculoskeletal, you'd be fascinated by what it does to your muscles and your bones and it's regenerative. News flash, it's not actually dissolving your muscles and bones, regardless of what you're hearing out there, regardless of what some of these huge influencers who should know better, who seem to have a good handle on literature are saying to you. It does not turn your bones to dust.
In fact, it's anabolic and healing to your bones from what I can tell. And I have a whole lesson about it. Pancreatitis, like I said, renal, so kidney health, there's a whole lesson on there in kidneys and GLP-1. Thyroid cancer. I know that's a big one that people want to hear about. That's in the cancer lesson. And then type 2 diabetes, metabolic health. I'm working on more about weight loss.
But yeah, I've got data up to my ears. I've got a 40-plus page document in there in the big course that you can have access to when you join that big program. It's all the studies. It's organized by body system. So again, this is for clinicians and for healthcare professionals, but I'm letting the general public in as of now. And that's not going to be for long. We're at the end of April.
I'm pulling it down probably in the next 30 days. I'm going to be revamping it. And when I relaunch it, the general public version is going to be much, much simpler. way less clinical.
So if you're one of those people and you really like to chew on the information and you really want that deep dive and you're smarty pants and you want access to all the data and you want access to all the information, grab it while it is in this iteration because it won't be this way for very long. So I'm a total fish oil snob. I always have been. Most fish oil is rancid junk.
It's the sewer of the sea, if you will. That's why I take Puree's Omega-3. I trust it full stop. Not only are you getting a potent 2,000 milligrams of EPA and DHA, the long chain Omega-3s that actually move the needle, delivered in their natural triglyceride form at 80% concentration, that's rare. But the quality is unmatched.
It's IFOS certified with a perfect five-star rating for purity, freshness, and label accuracy. It's certified clean by the Clean Label Project. It's certified sustainable by Friends of the Sea. And it's third-party tested against 200 contaminants, including heavy metals, pesticides, dioxins, and bisphenols. Even better, you can scan the QR code on the bottle to see your exact batches results.
Total transparency. Interestingly, a 2024 randomized controlled trial came out of clinical nutrition looking at healthy older women ages 60 to 80 and the effects of omega-3 fish oil supplementation on muscle loss and recovery during disuse like after bedrest or injury. The result, omega-3s preserve muscle strength and function and even enhanced recovery after inactivity. That's huge.
Showing 281–300 of 1,621 · page 15 of 82
← Previous
Next →